484 Results (Page 11 of 20)
Brazil Markets Research Reports
Brazil Anemia Therapeutics Market Analysis
The Brazil Anemia Therapeutics Market is anticipated to experience growth from $370 Mn in 2022 to $799 Mn by 2030, with a CAGR of 10.10% during the forecast period of 2022–2030. Factors such as the demography and disease burden in Brazil, increasing adaptation of healthcare innovations and advancements, and lenient and fast regulatory policies, drive market growth. The Brazil Anemia Therapeutics Market encompasses various players across different segments, including Amgen, Roche, Novartis, Eli Lilly, Sanofi, Cristalia Pharma, Ache Laboratories, EMS Pharma, Eurofarma, BioLab Pharma, etc, among various others
Brazil Alopecia (Hair Loss) Therapeutics Market Analysis
The Brazil Alopecia (Hair Loss) Therapeutics Market was valued at US $205 Mn in 2022, and is predicted to grow at (CAGR) of 8.5% from 2023 to 2030, to US $394 Mn by 2030. The key drivers of this industry include the surge in the prevalence of alopecia (hair loss), increased disposable income, lifestyle changes, and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Merck, Cipla, Sun Pharmaceuticals, Theradome, and Pfizer, among others.
Brazil Digital Therapeutics Market Analysis
Brazil Digital Therapeutics Market is at around $0.16 Bn in 2023 and is projected to reach $0.89 Bn in 2030, exhibiting a CAGR of 28.2% during the forecast period. The market is expanding due to rising awareness and acceptance, technological advancements, and government policies and directives. The market is dominated by key players like Dr. Consulta, Pixeon, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
Brazil Allergy Therapeutics Market Analysis
Brazil Allergy Therapeutics Market was valued at $580 Mn in 2022 and is estimated to reach $1027 Mn in 2030, exhibiting a CAGR of 7.4% during the forecast period. The growing prevalence of allergic disorders and related medical issues is driving growth in the market for allergy treatment drugs. The top leading pharmaceutical companies operating in the market are GlaxoSmithKline (GSK), Sanofi, Merck & Co., Novartis, Bayer, Johnson & Johnson, Teva Pharmaceutical Industries, Chiesi Farmaceutici, Eurofarma Laboratórios and EMS.
Brazil Alcohol Addiction Therapeutics Market Analysis
The Brazil Alcohol Addiction Therapeutics Market is valued at around $18 Mn in 2022 and is projected to reach $31 Mn by 2030, exhibiting a CAGR of 7.3% during the forecast period. The intensified commitment of the Brazilian government to mental health, coupled with the urbanization-induced surge in alcohol consumption, is fuelling a rising need for treatment solutions. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Brazil are Alkermes, TEVA, Otsuka, GlaxoSmithKline, BioCorRx, Adial Pharmaceuticals, Kinnov Therapeutics, Opiant, MediciNova, Corcept Therapeutics, among others
Brazil Actinic Keratosis Therapeutic Market Analysis
Brazil actinic keratosis therapeutic market is expected to expand at a CAGR of 5.9% from $170 Mn in 2022 to $269 Mn by 2030. The market is anticipated to be pushed by several reasons, the most important of which are the rising incidence of AK and the effects of expanding healthcare coverage, public awareness campaigns, treatment option developments, and an altering healthcare environment. Global giants like AbbVie, Galderma, Merck, and Medacris coexist with smaller regional firms like Aché Laboratórios and Hypermarcas as major participants in Brazil, which is constantly changing as a result of patent expirations and possible new entries.
Brazil Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The Brazil Acute Lymphocytic Leukaemia (ALL) Therapeutics Market was valued at US $83 Mn in 2022, and is predicted to grow at (CAGR) of 8.8% from 2023 to 2030, to US $162 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic leukaemia cases, international collaborations and partnerships, increased government funding initiatives for new therapeutics, and other factors. The industry is primarily dominated by players such as SPIMACO, Julphar, Jamjoom, Novartis, Sanofi, Pfizer Inc, among other players.
Brazil Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The Brazil Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $ 28 Mn in 2022, and is predicted to grow at (CAGR) of 6.8% from 2023 to 2030, to US $47 Mn by 2030. The key drivers of this industry include the upward trend in the incidence of autosomal dominant polycystic kidney disease, government initiatives and other factors. The industry is primarily dominated by players such as Otsuka, Sanofi, Roche, Biogen, Vertex, Janssen among others
Brazil Age-Related Macular Degeneration Therapeutics Market Analysis
The Brazil Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $270 Mn in 2022 and is predicted to grow at a CAGR of 9.9% from 2023 to 2030, to US $575 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, the evolving healthcare landscape, and other factors. The industry is primarily dominated by players such as Regeneron Pharmaceuticals, Novartis, Bayer, Roche, and Genetech, among others
Brazil Addiction Therapeutics Market Analysis
Brazil addiction therapeutics market was valued at $253 Mn in 2022 and is estimated to reach $464 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The industry has grown as a result of several awareness efforts and government programs designed to discourage drug addiction and support medicine. Innovations in this field are being driven by major participants in the industry, including Pfizer, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries, Titan Pharmaceutical, Novartis, Cipla, Mylan, Glenmark, and Alkermes.
Brazil Oral Care Market Analysis
Brazil's oral care market was valued at $881 Mn in 2022 and is estimated to expand at a CAGR of 7.2% from 2022 to 2030 and will reach $1536 Mn in 2030. One of the main reasons propelling the growth of this market is technological advancements and increasing disposable income. The market is segmented by type, drug, and distribution channel. Some key players in this market are Fresh Up Italia, The Procter & Gamble Company, Fresh, Condor Sa, Colgate-Palmolive, Johnson & Johnson, Dentek Oral Care, Hypermarcas, Acryline, GlaxoSmithKline Prestige Brands among others.
Brazil Radiotherapy Market Analysis
By 2030, it is anticipated that the Brazil Radiotherapy Market will reach a value of $297 Mn from $173 Mn in 2022, growing at a CAGR of 7% during 2022-30. The Radiotherapy Therapeutics Market in Brazil is dominated by a few domestic players such as Accuray, Varian Medical Systems, and Accuray. The radiotherapy market in Brazil is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Brazil Radiotherapy is increasing on account of the rise in cancer cases in the country.
Brazil Neurology Devices Market Analysis
Brazil's Neurology Device Market size is at around $316 Mn in 2022 and is projected to reach $619 Mn in 2030, exhibiting a CAGR of 8.8% during the forecast period. Brazil has a high incidence of neurological disorders such as epilepsy, Parkinson's disease, and migraine, which is driving demand for neurology devices that is captured by both local and international players like Neuroservice, Neurosoft, NeuroRx, Medtronic, and Boston Scientific. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
Brazil Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Brazil Lung Cancer Therapeutics Market will reach a value of $1496 Mn from $745 Mn in 2022, growing at a CAGR of 9.1% during 2022-30. The Lung Cancer Therapeutics Market in Brazil is dominated by a few domestic pharmaceutical companies such as Eurofarma, Aché Laboratórios, and Libbs. The Lung Cancer Therapeutics Market in Brazil is segmented into different types of cancer and different therapy types. Some of the major factors affecting Brazil's lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies, and the presence of highly efficient drugs.
Brazil ENT Devices Market Analysis
Brazil's ENT Devices Market is projected to grow from $580 Mn in 2022 to $980 Mn by 2030, registering a CAGR of 6.8% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Brazil ENT devices market include KOLPLAST, Newmed, and Soniclease.
Brazil ECG Equipments Market Analysis
Brazil's ECG Equipment Market is expected to witness growth from $223 Mn in 2022 to $422 Mn in 2030 with a CAGR of 8.30% for the forecasted year 2022-30. Brazilians are becoming more and more conscious of the value of preventive healthcare, which includes routine physicals and heart disease screenings. This has increased the need for ECG equipment. The market is segmented by product type and by the end user. Some key players in this market include Baumer SA, Medlevensohn, Contatti Medical, Johnson & Johnson, Philipps Healthcare, Medtronic, and Dexcom.
Brazil Diabetes Therapeutics Market Analysis
Brazil's diabetes therapeutics market is expected to grow from $3.59 Bn in 2022 to $8.11 Bn in 2030 with a CAGR of 10.7% for the forecasted year 2022-2030. The rising prevalence of diabetes in Brazil and the development of new and innovative treatment options in Brazil are driving the growth of the market. The Brazil diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Supera Farma, Granado, and AstraZeneca are the major players in the Brazilian diabetes therapeutics market.
Brazil Diabetes Devices Market Analysis
Brazil's Diabetes Devices Market is expected to witness growth from $568 Mn in 2022 to $1067 Mn in 2030 with a CAGR of 8.20% for the forecasted year 2022-2030. As healthcare expenditures in Brazil increase, a greater focus is being placed on preventive care and the management of chronic diseases. The demand for diabetes management devices, ought to increase as a result. The market is segmented by type and by the end user. Some key players in this market include: Nipro Medical do Brasil Ltda, Arthrocare do Brasil Ltda, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care, and Dexcom.
Brazil Coronary Stents Market Analysis
Brazil's Coronary Stents Market is expected to grow from $283 Mn in 2022 to $442 Mn in 2030 with a CAGR of 5.75% for the forecasted year 2022-30. Brazil has high rates of CAD incidence and prevalence, which raises serious public health concerns. As a result, there is an increasing need for coronary stents as a CAD treatment option, which is propelling market expansion. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include: Nipro Medical do Brasil Ltda, Arthrocare do Brasil Ltda, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
Brazil Contraceptive Devices Market Analysis
Brazil's Contraceptive Devices Market is expected to witness growth from $323 Mn in 2022 to $643 Mn in 2030 with a CAGR of 9.00% for the forecasted year 2022-30. In Brazil, there has been an increase in demand for contraceptive devices as a result of the emphasis being placed on family planning and contraception education and awareness. The market is segmented by type and by gender. Some key players in this market include Farmoquimica, Famivita, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, Pregna International, Eurofarma, and Teva Pharmaceutical.
Brazil Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
Brazil's Chronic Obstructive Pulmonary Disease (COPD) therapeutics market was valued at $456 Mn in 2022 and is estimated to expand at a CAGR of 8.1% from 2022-30 and will reach $851 Mn in 2030. One of the main reasons propelling the growth of this market is urbanization aging population. The market is segmented by drug class and by distribution channel. Some key players in this market are Aché Laboratories, Cristália Products Químicos Pharmaceutics, Eurofarma Laboratories, Laboratórios Teuto Brasileiro, EMS Sigma Pharma, Astellas Pharma, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, Teva Brazil Limited and others.
Brazil Cardiac Surgery Instruments Market Analysis
Brazil's Cardiac Surgery Instruments Market is expected to witness growth from $52 Mn in 2022 to $93 Mn in 2030 with a CAGR of 7.60% for the forecasted year 2022-30. Heart diseases like coronary artery disease and heart failure are very common in Brazil. Due to the rise in cardiac surgeries as a result, there is an increasing need for the tools and instruments used in these operations. The market is segmented by type, application, and end user. Some key players in this market include: Nipro Medical do Brasil Ltda, Arthrocare do Brasil Ltda, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Brazil Cancer Immunotherapy Market Analysis
Brazil's cancer immunotherapy market is expected to witness growth from $2.8 Bn in 2022 to $5.2 Bn in 2030 with a CAGR of 8.1% for the forecasted year 2022-30. The improvement in healthcare infrastructure and the growing demand for novel cancer immunotherapies in Brazil are driving the expansion of the market. The Brazil cancer immunotherapy market is segmented by type, application, and end user. Genera, Loccus, and Eli Lily are the major players in Brazil's cancer immunotherapy market.
Brazil Anti Aging Therapeutics Market Analysis
Brazil's anti-aging therapeutics market is projected to grow from $15 Mn in 2022 to $55 Mn in 2030 with a CAGR of 17.53% for the year 2022-30. The growing disposable income in Brazil and the rise in the geriatric population in Brazil are expected to drive the expansion of the market. The Brazilian anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and distribution channel. Some of the key competitors in the market are Signo Vinces, Plantus, and Betterhumans.
Brazil Acne Drugs Market Analysis
This report presents a strategic analysis of the Brazil Acne Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Brazil Acne Drugs Market, offering unmatched value, accuracy, and expert insights.